Health ❯ Healthcare ❯ Immunotherapy

Cancer Immunotherapy

Neoantigens mRNA-based Immunotherapy Neoantigen Vaccines Nivolumab Vaccine Development KRAS-targeted Therapies Immune-Independent Therapies Durvalumab Pembrolizumab Pancreatic Cancer Intratumoral Therapy Tumor-Associated Macrophages MHC Class II Targeted Therapy HER2 Positive Breast Cancer T-cell Infiltration Nanoinmunotherapy Personalized Cancer Immunotherapy

KRAS Vaccine Safely Triggers Lasting Immune Response in People at High Risk for Pancreatic Cancer

The small phase 1 trial shows durable KRAS-specific T cells after vaccination with clinical prevention still unproven.

Triple Therapy Counters Endocrine Resistance in ER+ Breast Cancer in Preclinical Study

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Pre-Surgery Nivolumab and Chemotherapy Improve Five-Year Survival in Operable Lung Cancer